HemaCare BioScience

HemaCare is a global leader in the supply and customization of human-derived biological products and services for biomedical research, drug discovery, and cell therapy development. Founded in 1978 and headquartered in Northridge, California, the company provides high-quality starting materials such as leukopaks, bone marrow, and cord blood, as well as isolated primary cells like T cells, B cells, and stem cells. HemaCare's products are critical inputs for the discovery and manufacturing of advanced therapies, having supported the development of all FDA-approved cell therapies to date. In 2020, the company was acquired by Charles River Laboratories to enhance its early-stage discovery and manufacturing support services. The company operates FDA-registered, GMP-compliant facilities to ensure the highest standards of quality and regulatory compliance for its global client base.